The National Kidney Cancer Audit (NKCA) evaluates patterns of care and outcomes for people diagnosed with kidney cancer in England and Wales. It aims to help NHS organisations benchmark their kidney cancer care against measurable standards, to identify unwarranted variation in measures of processes and outcomes, and to describe national levels and patterns of these measures in England and Wales.
The audit process looks at diagnosis and treatment, and how patients are managed. Cancer services obviously need to have the right support and expertise in order to provide the best possible care. One of the clinical co-leads on this audit, Amit Bahl, says it will help to identify significant gaps. You can hear more of his thoughts here:
Dr Amit Bahl, Clinical Lead (Oncology), National Kidney Cancer Audit
Kidney cancer charities also suggest this national audit can help identify new areas for research and provide better information for patients, with the aim of allowing them to live longer healthier lives.
Andrew Greaves, General Manager at Kidney Cancer UK
The clinical leads for NKCA, who alongside our Clinical Reference Group, ensure it is focusing on the right questions, are as follows:
- Professor Amit Bahl, Clinical Lead (Oncology), representing the British Uro-oncology Group (BUG).
- Professor Grant Stewart, Clinical Lead (Urology), representing the British Association of Urological Surgeons (BAUS).
This page will be updated regularly and we intend to keep everyone informed as fully as possible.
Contact details
Want to find out more? Reach out to us via email
- Email:
- [email protected]
Twitter: @NKCA_NATCAN
Bluesky: nkca-natcan.bsky.social
LinkedIn: NKCA